Showing results (841-850 of 896) with videos related to

Sort By:
Pageof 90
Clinical Genitourinary Cancer|February 17, 2016
Safety and Feasibility of Laparoscopic Nephrectomy for Big Tumors (≥ 10 cm): A Retrospective Multicentric StudyGrégory Verhoest, Jean-Philippe Couapel, Emmanuel Oger, et al.
Contemporary Clinical Trials Communications|November 18, 2024
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and reportAngela Meade, Elena Frangou, Babak Choodari-Oskooei, et al.
European Urology Focus|July 1, 2026
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS)Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al.
BMC Cancer|July 11, 2023
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designsHilin Yildirim, Christiaan V Widdershoven, Maureen Jb Aarts, et al.
European Urology Oncology|August 27, 2025
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort StudySaeed Dabestani, Nessn H Azawi, Riccardo Campi, et al.
British Journal of Cancer|June 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)Grant D Stewart, Sarah J Welsh, Stephan Ursprung, et al.
BJUI Compass|April 23, 2025
A modified Delphi consensus statement on the role of biopsy in small renal massesDarryl E Bernstein, Hannah Warren, Joseph Santiapillai, et al.
European Urology Open Science|January 18, 2021
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day OutcomesWei Shen Tan, Rajan Arianayagam, Pramit Khetrapal, et al.
BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[99mTc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.
Pageof 90